K(ATP)-channel activation: Effects on myocardial recovery from ischaemia and role in the cardioprotective response to adenosine A1-receptor stimulation

British Journal of Pharmacology

Volumn 124, Issue 4, 1998, Pages 639-646

  Ford, William R ^a   Lopaschuk, Gary D ^a   Schulz, Richard ^a   Clanachan, Alexander S ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Adenosine A1 receptors; Cardioprotection; Cromakalim; Glibenclamide; Glucose oxidation; Glycolysis; K(ATP) channels; Myocardial ischaemia; N6 cyclohexyladenosine

Indexed keywords

ADENOSINE A1 RECEPTOR; CROMAKALIM; CYCLOHEXYLADENOSINE; GLIBENCLAMIDE; GLUCOSE; INSULIN; PALMITIC ACID; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM CHANNEL STIMULATING AGENT;

ANIMAL TISSUE; ARTICLE; GLUCOSE METABOLISM; GLUCOSE OXIDATION; GLYCOLYSIS; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HEART MUSCLE REPERFUSION; HEART PROTECTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ADENOSINE; ADENOSINE TRIPHOSPHATE; ANIMALS; BLOOD PRESSURE; CORONARY CIRCULATION; GLUCOSE; MALE; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION; POTASSIUM CHANNELS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PURINERGIC P1; VASCULAR RESISTANCE; VENTRICULAR FUNCTION, LEFT;

EID: 0031860863     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701872     Document Type: Article

References (56)

1. BILLMAN, G.E., AVENDANO, C.E., HALLIWILL, J.R. & BURROUGHS, J.M. (1993). The effects of the ATP-dependent potassium channel antagonist, glyburide, on coronary flow and susceptibility to ventricular fibrillation in unanesthetized dogs. J. Cardiovasc. Pharmacol., 21, 197-204.
2. BOURDILLON, P.D.V. & POOLE-WILSON, P.A. (1981). Effects of ischemia and reperfusion on calcium exchange and mechanical function in isolated rabbit myocardium. Cardiovasc. Res., 15, 121-130.
3. BRIL, A., LAVILLE, M-P., GOUT, B. (1992). Effects of glibenclamide on ventricular arrhythmias and cardiac function in ischaemia and reperfusion in isolated rat heart. Cir. Res., 26, 1069-1076.
4. CHI, L., UPRICHARD, A.C.G. & LUCCHESI, B. (1990). Profibrillatory actions of pinacidil in a conscious canine model of sudden coronary death. J. Cardiovasc. Pharmacol., 15, 452-464.
5. COETZEE, W.A. (1992). ATP-sensitive potassium channels and myocardial ischemia: Why do they open? Cardiovasc. Drugs Ther., 6, 201-208.
6. + channels in cardiac ischemia: An endogenous mechanism for protection of the heart. Cardiovasc. Drugs Ther., 7, 527-537.
7. D'ALONZO, A.J., DARBENZIO, R.B., PARHAM, C.S. & GROVER, G.J. (1992). Effects of intracoronary cromakalim on postischemic contractile function and action potential duration. Cardiovasc. Res., 26, 1046-1053.
8. DENNIS, S.C., GEVERS, W. & OPIE, L.H. (1991). Protons in ischemia: where do they come from; where do they go to? J. Mol. Cell. Cardiol., 23, 1077-1086.
9. + channels in isolated cardiac myocytes. Biochem. Biophys. Res. Commun., 154, 620-625.
10. FELDMAN, J.M. (1985). Glyburide: a second-generation sulfonylurea hypoglycemic agent. History, chemistry, metabolism, pharmacokinetics, clinical use and adverse effects. Pharmacotherapy, 5, 43-62.
11. ATP channel modulation in working rat hearts with coronary occlusion: effects of cromakalin, cicletanine, and glibenclamide. Cardiovasc. Res., 30, 781-787.
12. FINEGAN, B.A., LOPASCHUK, G.D., COULSON, C.S. & CLANACHAN, A.S. (1993). Adenosine alters glucose use during ischemia and reperfusion in isolated rat hearts. Circulation, 87, 900-908.
13. 1 receptor mediated stimulation during reperfusion following ischaemia. Br. J. Pharmacol., 118, 355-363.
14. FOX, J.S., WHITEHEAD, E.M. & SHANKS, R.G. (1991). Cardiovascular effects of cromakalim (BRL 34915) in healthy volunteers. Br. J. Clin. Pharmacol., 32, 45-49.
15. ATP-channel as a receptor for potassium channel openers. J. Biol. Chem., 271, 8796-8799.
16. GOLDBERG, M.R., SUSHAK, C.S., ROCKHOLD, F.W. & THOMPSON, W.L. (1988). Vasodilator monotherapy in the treatment of hypertension: comparative efficacy and safety of pinacidil, a potassium channel opener, and prazosin. Clin. Pharmacol. Ther., 44, 78-92.
17. GROSS, G.J. & AUCHAMPACH, J.A. (1992). Role of ATP dependent potassium channels in myocardial ischaemia. Cardiovasc. Res., 26, 1011-1016.
18. GROVER, G.J. (1994). Protective effects of ATP-sensitive potassium channel openers in experimental myocardial ischemia. J. Cardiovasc. Pharmacol., 24, S18-S27.
19. 1 receptors in ischemic rat hearts. Cardiovasc. Res., 31, 511-517.
20. ATP opener cromakalim is not correlated with ischemic myocardial action potential duration. J. Cardiovasc. Pharmacol., 26, 145-152.
21. GROVER, G.J., DZWONCZYK, S. & SLEPH, P.G. (1990a). Reduction of ischemic damage in isolated rat hearts by the potassium channel opener RP 52891. Eur. J. Pharmacol., 191, 11-19.
22. GROVER, G.J., SLEPH, P.G. & PARHAM, C.S. (1990b). Nicorandil improves postischemic contractile function independently of direct myocardial effects. J. Cardiovasc. Pharmacol., 15, 698-705.
23. 0 of myocardial infarct size in the rabbit by activation of ATP-sensitive channels. Br. J. Pharmacol., 166, 2435-2440.
24. 1 receptors by G proteins in rat ventricular myocytes. Am. J. Physiol., 259, H820-H826.
25. KITZEN, J., MCCALLUM, J.D., HARVEY, C., MORIN, M.E., OSHIRO, G.T. & COLATSKY, T.J. (1992). Potassium channel activators cromakalim and celikalim (WAY-120,491) fail to decrease myocardial infarct size in the anesthetized canine. Pharmacology, 45, 71-82.
26. 1 receptor mediated protection of the globally ischemic isolated rat heart. J. Mol. Cell. Cardiol., 22, 39-47.
27. 1 receptor mechanism. Am. J. Physiol., 263, H1460-H1465.
28. LAZDUNSKI, M., FRELIN, C. & VIGNE, P. (1985). The sodium/ hydrogen exchange system in cardiac cells: Its biological and pharmacological properties and its role in regulating internal concentrations of sodium and pH. J. Mol. Cell Cardiol., 17, 1029-1042.
29. LOPASCHUK, G.D., COLLINS-NAKAI, R., OLLEY, P.M., MONTAGUE, T.J., MCNEIL, G., GAYLE, M., PENKOSKE, P. & FINEGAN, B.A. (1994). Plasma fatty acid levels in infants and adults after myocardial ischemia. Am. Heart J., 128, 61-67.
30. LOPASCHUK, G.D., SPAFFORD, M.A., DAVIES, N.J. & WALL, S.A. (1990). Glucose and palmitate oxidation in isolated working rat hearts reperfused after a period of transient global ischemia. Circ. Res., 66, 546-553.
31. LOPASCHUK, G.D. & STANLEY, W.C. (1997). Glucose metabolism in the ischemic heart. Circulation, 95, 313-315.
32. LOPASCHUK, G.D., WAMBOLT, R.B. & BARR, R.L. (1993). An imbalance between glycolysis and glucose oxidation is a possible explanation for the detrimental effects of high levels of fatty acids during aerobic reperfusion of ischemic hearts. J. Pharmacol. Exp. Ther., 264, 135-144.
33. MAKIGUCHI, M., KAWAGUCHI, H., TAMURA, M. & YASUDA, H. (1991). Effect of palmitic acid and fatty acid binding protein on ventricular fibrillation threshold in the perfused rat heart. Cardiovasc. Drugs Ther., 5, 753-761.
34. MCVEIGH, W. & LOPASCHUK, G.D. (1990). Dichloroacetate stimulation of glucose oxidation improves recovery of ischemic rat hearts. Am. J. Physiol., 259, H1079-H1085.
35. 2+ modulation during postischemic reperfusion in rat heart. Am. J. Physiol., 268, H100-H111.
36. MITANI, A., KINOSITA, K., FUKAMACHI, K., SAKAMOTO, M., KURISU, K., TSURUHARA, Y., FUKUMURA, K., NAKASHIMA, A. & TOKUNAGA, K. (1991). Effects of glibenclamide and nicorandil on cardiac function during ischemia and reperfusion in isolated perfused rat hearts. Am. J. Physiol., 261, H1864-H1871.
37. NAYLER, W.G. (1981). The role of calcium in the ischemic myocardium. Am. J. Pathol., 102, 262-270.
38. OPIE, L.H. (1993). Modulation of ischemia by regulation of ATP-sensitive potassium channel. Cardiovasc. Drugs Ther., 7, 507-513.
39. PENNY, W.J. & SHERIDAN, D.J. (1983). Arrhythmias and cellular electrophysiological changes during myocardial 'ischaemia' and reperfusion. Cardiovasc. Res., 17, 363-372.
40. RANDALL, M.D. (1995). The involvement of ATP-sensitive potassium channels and adenosine in the regulation of coronary flow in the isolated perfused heart. Br. J. Pharmacol., 116, 3068-3074.
41. SADDIK, M. & LOPASCHUK, G.D. (1991). Myocardial triglyceride turnover and contribution to energy substrate utilization in isolated working rat hearts. J. Biol. Chem., 266, 8162-8170.
42. SCHAFFER, S.W., TAN, B.H. & MOZAFFARI, M.S. (1985). Effect of glyburide on myocardial metabolism and function. Am. J. Med. 79(suppl 3B), 48-52.
43. SIEGL, P. (1994). Blockers of ATP sensitive potassium current are of potential benefit in ischemic heart disease. Cardiovasc. Res., 28, 31-33.
44. TAN, B.H., WILSON, G.L. & SCHAFFER, S.W. (1985). Effect of tolbutamide on myocardial metabolism and mechanical performance of the diabetic rat. Diabetes, 33, 1138-1143.
45. 2+ overload and depressed recovery of ventricular function of reperfused ischemic rat hearts. Cir. Res., 65, 1045-1056.
46. +-channel-opening drugs. Am. J. Physiol., 269, C525-C545.
47. 1-selective adenosine analogues protects the heart against infarction. Circulation, 85, 659-665.
48. TOOMBS, C.F., MCGEE, D.S., JOHNSTON, W.E. & VINTEN-JOHANSEN, J. (1993). Protection from ischaemic-reperfusion injury with adenosine pretreatment is reversed by inhibition of ATP sensitive potassium channels. Cardiovasc. Res., 27, 623-629.
49. ++ manipulation prevents the proarrhythmic activity of cromakalim in ischemic/ reperfused diabetic hearts. J. Pharmacol. Exp. Ther., 282, 309-317.
50. TOSAKI, A. & HELLEGOUARCH, A. (1994). Adenosine triphosphate-sensitive potassium channel blocking agent ameliorates, but opening agent aggravates, ischemia/reperfusion-induced injury. J. Am. Coll. Cardiol., 23, 487-496.
51. ATP channel. Am. J. Physiol., 266, H829-H839.
52. + loss and cardiac function in ischemic and reperfused mammalian ventricle. Cir. Res., 71, 1324-1333.
53. + channels. Cardiovasc. Drugs. Ther., 7, 499-505.
54. ATP-channel opening and arrhythmogenesis. J. Cardiovasc. Pharmacol., 24, S35-S40.
55. ATP channels. Circulation, 89, 1229-1236.
56. YAO, Z. & GROSS, G.J. (1994b). The ATP-dependent potassium channel: An endogenous cardioprotective mechanism. J. Cardiovasc. Pharmacol., 24, S28-34.